Can Sputum Eosinophilia Be a Constant Feature in Severe Refractory Asthmatics? A 3-Year Longitudinal Study

International Archives of Allergy and Immunology

Volumn 166, Issue 4, 2015, Pages 287-290

  Dente, Federico L ^a   Latorre, Manuela ^a   Novelli, Federica ^a   Cianchetti, Silvana ^a   Bartoli, Maria Laura ^a   Bacci, Elena ^a   Di Franco, Antonella ^a   Vagaggini, Barbara ^a   Celi, Alessandro ^a   Paggiaro, Pierluigi ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Phenotypes; Severe asthma; Sputum eosinophils

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHILIA; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SPUTUM ANALYSIS; SPUTUM EOSINOPHILIA; AGED; FEMALE; IMMUNOLOGY; MALE; SPUTUM;

AGED; ASTHMA; EOSINOPHILIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SPUTUM;

EID: 84929683025     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000381853     Document Type: Article

References (13)

1. Simpson JL: Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11: 54-61.
2. D'Silva L, Cook RJ, Allen CJ, Hargreave FE, Parameswaran K: Changing pattern of sputum cell counts during successive exacerbations of airway disease. Respir Med 2007; 101: 2217-2220.
3. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV; Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute: A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012; 185: 612-619.
4. Bacci E, Latorre M, Cianchetti S, Bartoli M, Costa F, Di Franco A, Malagrin?L, Novelli F, Vagaggini B, Dente FL, Paggiaro P: Transient sputum eosinophilia may occur over time in non-eosinophilic asthma and this is not prevented by salmeterol. Respirology 2012; 17: 1199-1206.
5. Van Veen IH, ten Brinke A, Gauw S, Sterk PJ, Rabe KF, Bel EH: Consistency of sputum eosinophilis in difficult-to-treat asthma: a 5-year follow-up study. J Allergy Clin Immunol 2009; 124: 615-617.
6. Al-Samri MT, Benedetti A, Prefontaine D, Olivenstein R, Lemiere C, Nair P, Martin JG, Hamid Q: Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: a prospective study using multiple samples. J Allergy Clin Immunol 2010; 125: 1161-1163.
7. Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, Wagener AH, Wagers SS, Sterk PJ, Compton CH; Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome (U-Biopred) Consortium, Consensus Generation: Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 66: 910-917.
8. Dente FL, Carnevali S, Bartoli ML, Cianchetti S, Bacci E, Di Franco A, Vagaggini B, Paggiaro P: Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients. Ann Allergy Asthma Immunol 2006; 97: 312-320.
9. Belda J, Leigh R, Parameswaran K, O'Byrne PM, Sears MR, Hargreave FE: Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161: 475-478.
10. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ: Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353: 2213-2214.
11. Bousquet J, Mantzouranis E, Cruz AA, A?-Khaled N, Baena-Cagnani CE, Bleecker ER, Brightling CE, Burney P, Bush A, Busse WW, Casale TB, Chan-Yeung M, Chen R, Chowdhury B, Chung KF, Dahl R, Drazen JM, Fabbri LM, Holgate ST, Kauffmann F, Haahtela T, Khaltaev N, Kiley JP, Masjedi MR, Mohammad Y, O'Byrne P, Partridge MR, Rabe KF, Togias A, van Weel C, Wenzel S, Zhong N, Zuberbier T: Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926-938.
12. Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, Lenczewska D, Bodzenta-Lukaszyk A: RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy. Int Arch Allergy Immunol 2011; 154: 25-32.
13. Ayars AG, Altman LC, Potter-Perigo S, Radford K, Wight TN, Nair P: Sputum hyaluronan and versican in severe eosinophilic asthma. Int Arch Allergy Immunol 2013; 161: 65-73.